Modifiable Risk Factors Linked to Late Stages of Chronic Kidney Disease in Saudi Arabia
Life Sciences -Medicine
DOI:
https://doi.org/10.22376/ijlpr.2023.13.4.L107-L112Keywords:
Chronic Kidney disease, hypertension, Diabetes, herbal, obesity, Saudi ArabiaAbstract
The present study aims to identify modifiable risk variables associated with late-stage chronic renal disease (CKD) in Saudi Arabia. During a cross-sectional survey in the Hail region, 256 Saudi participants were recruited for this study. Participants were chosen based on their estimated GFR. Only CKD patients in stages III, IV or V were eligible. Females had a higher prevalence of CKD, but male patients had a higher risk of end-stage disease, with an RR (95% CI) of 3.2893 (1.4416 to 7.5055), P = 0.0047. Hypertension was found in 62% of the participants (43% in Stage IV and 45.5% in Stage V). T2DM was found in 54% of the patients, with 60% having Stage IV and 27% having Stage V. Nonsteroidal anti-inflammatory medicines (NSAIDs) were used by 23% of the individuals (including 27% in Stage IV and 27% in Stage V). Herbal treatment was used by 21% of the patients (including 27% Stage IV and 36% Stage V). Late-stage CKD is prevalent in Saudi Arabia and is more common among women, rural residents, and people over 55. The findings of this study indicate that hypertension, diabetes, herbal medication use, nonsteroidal anti-inflammatory drugs (NSAIDs), and obesity are responsible for the increased prevalence of CKD in Saudi Arabia. Awareness and education programs focusing on modifiable risk factors for CKD are suggested for lowering the CKD prevalence rate.
References
Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021;398(10302):786-802. doi: 10.1016/S0140-6736(21)00519-5.
Laffin LJ, Bakris GL. The intersection between chronic kidney disease and cardiovascular disease. Curr Cardiol Rep. 2021 Jul 16;23(9):117. doi: 10.1007/s11886-021-01546-8, PMID 34269921.
Kaze FF, Maimouna M, Beybey AF, Pefura-Yone EW, Balkissou AD, Halle MP, et al. Prevalence and determinants of chronic kidney disease in urban adults' populations of northern Cameroon. Clin Exp Nephrol. 2021;25(7):718-26. doi: 10.1007/s10157-021-02036-5, PMID 33651200.
Kelly DM, Ademi Z, Doehner W, Lip GYH, Mark P, Toyoda K, et al. Chronic kidney and cerebrovascular disease: consensus and guidance from a KDIGO controversies conference. Stroke. 2021;52(7):e328-46. doi: 10.1161/STROKEAHA.120.029680, PMID 34078109.
Mousa D, Alharbi A, Helal I, Al-Homrany M, Alhujaili F, Alhweish A, et al. Prevalence and associated factors of chronic kidney disease among relatives of hemodialysis patients in Saudi Arabia. Kidney Int Rep. 2021;6(3):817-20. doi: 10.1016/j.ekir.2020.12.029, PMID 33732996.
Ahmed HG, Ginawi IA. Al-hazimi AM. Prevalence estimates of chronic kidney disease in hail region, KSA: in a comprehensive survey. Int J Sci Res. 2014;3:252-56.
Ahmed HG, Alzayed FSM, Albluwe HKA, Alosayfir ZAS, Aljarallah MYJ, Alghazi BKM et al. Etiology of chronic kidney disease (CKD) in Saudi Arabia. Int J Med Res Health Sci. 2019;8(5):177-82.
Dai H, Alsalhe TA, Chalghaf N, Riccò M, Bragazzi NL, Wu J. The global disease burden attributable to high body mass index in 195 countries and territories, 1990-2017: an analysis of the Global Burden of Disease Study. PLOS Med. 2020;17(7):e1003198. doi: 10.1371/journal.pmed.1003198, PMID 32722671.
Nahlah Fahad A, Ahmed Alkhateeb A, Rabah Alsharari A, Naif Alharbi A, Abdullaziz Hamed A. Measuring the awareness of chronic kidney disease (CKD) with environmental evaluation among adult diabetic patients in hail region, Saudi Arabia. J Environ Public Health. 2022;2022:4505345. doi: 10.1155/2022/4505345, PMID 35815250.
Alghamdi A, Alaryni A, AlMatham K, Hakami O, Qutob R, Bukhari A et al. Knowledge, attitudes, and practices of high-risk patients towards prevention and early detection of chronic kidney disease (CKD) in Saudi Arabia. Int J Environ Res Public Health. 2023;20(1):871. doi: 10.3390/ijerph20010871, PMID 36613189.
Assiry A, Alshahrani S, Banji D, Banji OJF, Syed NK, Alqahtani SS. Public awareness of chronic kidney disease in Jazan Province, Saudi Arabia-A cross-sectional survey. Healthcare (Basel). 2022;10(8):1377. doi: 10.3390/healthcare10081377, PMID 35893199.
Alobaidi S. Knowledge of chronic kidney disease among the Saudi Arabian population was evaluated using a validated questionnaire: A cross-sectional study. Patient Prefer Adherence. 2021;15:1281-8. doi: 10.2147/PPA.S315369, PMID 34163145.
Al-Husayni F, Al-Zahrani A, Zwawy M, Alamri S, Aljedaani R, Almalki A. The awareness and perception of chronic kidney disease in Jeddah, Saudi Arabia. Saudi J Kidney Dis Transpl. 2021;32(2):488-96. doi: 10.4103/1319-2442.335461, PMID 35017343.
Jalal SM, Beth MRM, Bo Khamseen ZM. Impact of hospitalization on the quality of life of patients with chronic kidney disease in Saudi Arabia. Int J Environ Res Public Health. 2022;19(15):9718. doi: 10.3390/ijerph19159718, PMID 35955072.
Hussien H, Apetrii M, Covic A. Health-related quality of life in patients with chronic kidney disease. Expert Rev Pharmacoecon Outcomes Res. 2021;21(1):43-54. doi: 10.1080/14737167.2021.1854091, PMID 33213186.
Delanaye P, Glassock RJ, Pottel H, Rule AD. An age-calibrated definition of chronic kidney disease: rationale and benefits. Clin Biochem Rev. 2016;37(1):17-26. PMID 27057075.
Jayaraman K, Theou O, Godin J, Mayo A, Cahill L, Rockwood K. Relationship of body mass index with frailty and all-cause mortality among middle-aged and older adults. BMC Med. 2022;20(1):404. doi: 10.1186/s12916-022-02596-7, PMID 36280863.
Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151-64. doi: 10.1038/graph.2017.181, PMID 29355169.
Ravani P, Quinn R, Fiocco M, Liu P, Al-Wahsh H, Lam N et al. Association of age with risk of kidney failure in adults with Stage IV chronic kidney disease in Canada. JAMA Netw Open. 2020;3(9):e2017150. doi: 10.1001/jamanetworkopen.2020.17150, PMID 32945876.
Kaze FF, Meto DT, Halle MP, Ngogang J, Kengne AP. Prevalence and determinants of chronic kidney disease in rural and urban Cameroonians: a cross-sectional study. BMC Nephrol. 2015;16:117. doi: 10.1186/s12882-015-0111-8, PMID 26220538.
Banerjee D, Winocour P, Chowdhury TA, De P, Wahba M, Montero R, et al. Management of hypertension in patients with diabetic kidney disease: summary of the joint association of British Clinical Diabetologists and UK kidney association (ABCD-UKKA) guideline 2021. Kidney Int Rep. 2022;7(4):681-7. doi: 10.1016/j.ekir.2022.01.004, PMID 35497783.
Jha V. Herbal medicines and chronic kidney disease. Nephrology (Carlton). 2010;15;Suppl 2:10-7. doi: 10.1111/j.1440-1797.2010.01305.x, PMID 20586941.
Silva Junior GB, Ferreiro Fuentes A, Nangaku M, Remuzzi G, Ronco C, editors. Nephrology and public health worldwide. Contrib Nephrol. 2021;199:143-54. doi: 10.1159/000517693.
Asif M. A brief study of toxic effects of some medicinal herbs on the kidney. Adv Biomed Res. 2012;1:44. doi: 10.4103/2277-9175.100144, PMID 23326775.
Chen J, Tsim KWK, Zhao YY [editorial]. Editorial: Applications of herbal medicine to control chronic kidney disease. Front Pharmacol. 2021;12:742407. doi: 10.3389/fphar.2021.742407, PMID 34557105.
Wan EYF, Yu EYT, Chan L, Mok AHY, Wang Y, Chan EWY et al. Comparative risks of nonsteroidal anti-inflammatory drugs on CKD. Clin J Am Soc Nephrol. 2021;16(6):898-907. doi: 10.2215/CJN.18501120, PMID 33910887.
Nderitu P, Doos L, Jones PW, Davies SJ, Kadam UT. Nonsteroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review. Fam Pract. 2013;30(3):247-55. doi: 10.1093/fampra/cms086, PMID 23302818.
Kovesdy CP, Furth SL, Zoccali C. Obesity and kidney disease: hidden consequences of the epidemic. Am J Nephrol. 2017;45(3):283-91. doi: 10.1159/000458467.
Kovesdy CP, Furth SL, Zoccali C, World Kidney Day Steering Committee. Obesity and kidney disease: hidden consequences of the epidemic. Can J Kidney Health Dis. 2017;4:2054358117698669. doi: 10.1177/2054358117698669, PMID 28540059.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Hessa Abdullah Alshammari, Fahad Khalid Alquwaiay, Hamoud Fahad Aldhamadi, Abdulkarim Ali Alqufayi, Ahmed A. Alrashidi, Faisal Saud Mohammed Alzayed, Omar Ali Alshammari, Saleh Ahmed Alogla, Hussain Gadelkarim Ahmed
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
